[New guideline for transfusion medicine]

Area of Science:

• Hematology
• Clinical Pathology
• Health Policy

Context:

• Revised guidelines for Transfusion Practice (TP) and Blood Products for Transfusion (BPfT) align with the 2003 New Blood Law.
• Focus on safe and appropriate TP, including avoiding mismatched transfusions and ensuring sufficient safe blood product supply.
• Addresses domestic demand for blood products.

Purpose:

• To outline essential components of a hospital management system for appropriate TP.
• To detail new criteria for the indication of blood products for transfusion (BPfT).
• To promote safe and effective blood transfusion practices.

Summary:

• Establishes requirements for a practical TP management system, emphasizing active hospital transfusion committee (HTC) involvement.
• Highlights the need for a dedicated transfusion service with laboratory testing, a responsible physician, a manual, and 24-hour support.
• Recommends autologous blood transfusion as the safest option when systems permit.
• Presents detailed criteria for BPfT, including inappropriate use, trigger levels, dosage, and effectiveness evaluation.

Impact:

• Enhances patient safety by minimizing transfusion risks.
• Improves the efficiency and appropriateness of blood product utilization.
• Provides a framework for standardized and effective transfusion services within hospitals.
• Contributes to better clinical outcomes through optimized transfusion management.